$15.19
arrow_drop_up1.19%There's no data available for key stats
There's no data available for ratios/profitability stats
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Celcuity To Participate in Jefferies Global Healthcare Conference
Celcuity Announces Pricing of Underwritten Common Stock Offering
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences